Please login to the form below
Data by
17
Revenue 2014Novo Nordisk
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Novo Nordisk's 2013 sales performance.
Novo's semaglutide beats Lilly's Trulicity in diabetes contest
Novo Nordisk says its once-weekly GLP-1 agonist semaglutide could become a "new standard" in type 2 diabetes after beating rival Eli Lilly's Trulicity (dulaglutide) in a phase III ... Both differences were statistically significant according to Novo,
Novo Nordisk bolsters management team
Danish pharmaceutical company Novo Nordisk has appointed Camilla Sylvest (pictured right) as its executive vice president in charge of commercial strategy and corporate affairs. ... for developing Novo Nordisk as a responsible corporation focused on the
Type 2 diabetes market set to soar, says GlobalData
However the race is still on in the type 2 diabetes space, although Novo Nordisk had a slight lead last year with sales of almost $18bn thanks to diabetes drugs such
Hayward Medical strengthens management team
Thomas joined the agency back in January after serving Aegate as its business development director and has previously held roles with Quintiles and Novo Nordisk.
Audit exposes gaps in pharma's promises on trial transparency
transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo Nordisk, Boehringer Ingelheim, Amgen, Merck &Co and AbbVie.
| Global revenue 2014 |
|---|
| 1: Novartis |
| 2: Pfizer |
| 3: Roche |
| 4: Sanofi |
| 5: Merck & Co. |
| 6: Johnson & Johnson |
| 7: GlaxoSmithKline |
| 8: AstraZeneca |
| 9: Gilead Sciences |
| 10: Takeda |
| 11: AbbVie |
| 12: Amgen |
| 13: Teva |
| 14: Lilly |
| 15: Bristol-Myers Squibb |
| 16: Bayer |
| 17: Novo Nordisk |
| 18: Astellas |
| 19: Boehringer Ingelheim |
| 20: Actavis |
| 21: Otsuka |
| 22: Daiichi Sankyo |
| 23: Biogen Idec |
| 24: Baxter |
| 25: Merck KGaA |
| US revenue 2014 |
|---|
| 1: Gilead Sciences |
| 2: Johnson & Johnson |
| 3: Pfizer |
| 4: Roche |
| 5: Novartis |
| 6: Amgen |
| 7: Merck & Co. |
| 8: Sanofi |
| 9: AbbVie |
| 10: Actavis |
| 11: AstraZeneca |
| 12: GlaxoSmithKline |
| 13: Lilly |
| 14: Bristol-Myers Squibb |
| 15: Novo Nordisk |
| Metabolic revenue 2014 |
|---|
| 1: Novo Nordisk |
| 2: Sanofi |
| 3: Merck & Co. |
| 4: Lilly |
| 5: AstraZeneca |
| 6: Takeda |
| 7: Novartis |
| 8: Amgen |
| 9: Bayer |
| 10: Merck KGaA |
| 11: Salix Pharmaceuticals |
| 12: AbbVie |
| 13: Dainippon Sumitomo Pharma |
| 14: Kyowa Hakko Kirin |
| 15: Mitsubishi Tanabe |
| Biologic revenue 2014 |
|---|
| 1: Roche |
| 2: Amgen |
| 3: Novo Nordisk |
| 4: AbbVie |
| 5: Sanofi |
| 6: Johnson & Johnson |
| 7: Pfizer |
| 8: Merck & Co. |
| 9: Lilly |
| 10: Biogen Idec |
| 11: Merck KGaA |
| 12: GlaxoSmithKline |
| 13: Bristol-Myers Squibb |
| 14: Novartis |
| 15: Bayer |
Data by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
Featured jobs
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
-
Principal Medical Writer
-
Great salary and benefits
- Account Manager – Healthcare Advertising
-
Salary TBC
-
Editorial Director - BioScience
-
Competitive Salary
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Brand Manager
-
Competitive salary and package
- Principal Medical Writer, Medical Education Agency
-
£46, 000 – £56, 000 benefits
- Head of Communications - Based Cambridge
-
Excellent Basic and Flex Benefits
- JAM – Med Comms – Independent Agency
-
Salary TBC
- Freelance Medical Copywriter, Healthcare Advertising Agency
-
according to skills and experience
- Account Manager, Medical Communications
-
£30, 000-£40, 000
- Account Executive - Pharma and Life Sciences Brighton or Maccles...
-
Competitive Salary
- Senior Account Manager/ Account Director – Pharma and Life Scien...
-
Competitive Salary
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
Subscribe to our email news alerts
- Novartis trial marks ResearchKit first in MS
- Samsung deal with Takeda looks beyond biosimilars
- Ocrevus off to a flying start as Roche raises 2017 forecasts
- NICE set to reject Pfizer's leukaemia drug Besponsa
- Biocon backs away from biosimilar filings in Europe
- Astellas extends phase III programme for Rydapt rival gilteritinib
- Hugh Cole joins Jounce Therapeutics as chief business officer
- PharmaLex appoints Dr Adam King to its regulatory team
- The Pharma Wars Series
- Ironwood claims FDA OK for former AZ gout drug
- Astellas extends phase III programme for Rydapt rival gilteritinib
- What pharma marketers can learn from growth hacking?
Latest intelligence
- The Pharma Wars Series
- The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere...
- What pharma marketers can learn from growth hacking?
- Growth hackers instinctively blend technical skills with creative thinking...
- The sound of silence puts the squeeze on generics and biosimilars
- Medicines for Europe vows to get governments talking to realise potential...
Quick links
Infographics
